{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:50:16Z","timestamp":1783691416223,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Proteolytic enzymes have shown efficacy in cancer therapy. We present a combination of the two pro-enzymes Trypsinogen and Chymotrypsinogen A with potent <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> anti-tumour efficacy. A synergetic anti-tumour effect for Trypsinogen and Chymotrypsinogen A was determined at a ratio 1:6 (named PRP) using 24 human cancer cell lines. The antiangiogenic effect of PRP was analysed by matrigel-based tube formation and by fibrous capsule formation assays. Furthermore, cell invasion and wound healing assays together with qRT-PCR determination of epithelial-to-mesenchymal transition (EMT) markers were performed on human cancer cells treated with PRP. Additionally, <jats:italic>in vivo<\/jats:italic> pharmacokinetic studies were implemented and the PRP\u2019s anti-tumour efficacy was explored against orthotopic pancreatic and ovarian cancer tumours. PRP formulation was proven to inhibit <jats:italic>in vitro<\/jats:italic> angiogenesis, tumour growth, cancer cell migration and invasiveness; and to be an effective and well tolerated <jats:italic>in vivo<\/jats:italic> anti-tumour treatment. Finally, the clinical efficacy of a suppository formulation containing both pancreatic pro-enzymes in the context of a UK Pharmaceuticals Special Scheme was evaluated in advanced cancer patients. Consequently, PRP could have relevant oncological clinical applications for the treatment of advanced or metastatic pancreatic adenocarcinoma and advanced epithelial ovarian cancer.<\/jats:p>","DOI":"10.1038\/s41598-017-14571-x","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T09:34:44Z","timestamp":1508405684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-2347","authenticated-orcid":false,"given":"Macarena","family":"Per\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"L\u00f3pez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Nadaraia-Hoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4996-8261","authenticated-orcid":false,"given":"Juan A.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"14571_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2128","volume":"3","author":"NE Reticker-Flynn","year":"2012","unstructured":"Reticker-Flynn, N. E. et al. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat. Commun. \n                           3, 1122 (2012).","journal-title":"Nat. Commun."},{"key":"14571_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer \n                           2, 442\u2013454 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"14571_CR3","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation \n                           119, 1420\u20131428 (2009).","journal-title":"Journal of Clinical Investigation"},{"key":"14571_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0965-1748(95)00084-4","volume":"26","author":"BP Jord\u00e3o","year":"1996","unstructured":"Jord\u00e3o, B. P., Terra, W. R., Ribeiro, A. F., Lehane, M. J. & Ferreira, C. Trypsin secretion in Musca domestica larval midguts: A biochemical and immunocytochemical study. Insect Biochem. Mol. Biol. \n                           26, 337\u2013346 (1996).","journal-title":"Insect Biochem. Mol. Biol."},{"issue":"Suppl","key":"14571_CR5","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1007\/s002800170004","volume":"47","author":"M Wald","year":"2001","unstructured":"Wald, M. et al. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother. Pharmacol. \n                           47(Suppl), S16\u2013S22 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14571_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00006676-200405000-00009","volume":"28","author":"M Saruc","year":"2004","unstructured":"Saruc, M. et al. Pancreatic enzyme extract improves survival in murine pancreatic cancer. Pancreas \n                           28, 401\u2013412 (2004).","journal-title":"Pancreas"},{"key":"14571_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13402-013-0134-8","volume":"36","author":"M Per\u00e1n","year":"2013","unstructured":"Per\u00e1n, M., Marchal, J. A., Garc\u00eda, M. A., Kenyon, J. & Tosh, D. In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation. Cell. Oncol. \n                           36, 289\u2013301 (2013).","journal-title":"Cell. Oncol."},{"issue":"Suppl","key":"14571_CR8","first-page":"S38","volume":"47","author":"A Sakalov\u00e1","year":"2001","unstructured":"Sakalov\u00e1, A. et al. Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemother. Pharmacol. \n                           47(Suppl), S38\u2013S44 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl","key":"14571_CR9","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1007\/s002800170009","volume":"47","author":"J Beuth","year":"2001","unstructured":"Beuth, J. et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients\u2013results of an epidemiological multicentre retrolective cohort study. Cancer Chemother. Pharmacol. \n                           47(Suppl), S45\u2013S54 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl","key":"14571_CR10","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1007\/s002800170010","volume":"47","author":"T Popiela","year":"2001","unstructured":"Popiela, T., Kulig, J., Hanisch, J. & Bock, P. R. Influence of a complementary treatment with oral enzymes on patients with colorectal cancers\u2013an epidemiological retrolective cohort study. Cancer Chemother. Pharmacol. \n                           47(Suppl), S55\u2013S63 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"14571_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ncb875","volume":"4","author":"W Wood","year":"2002","unstructured":"Wood, W. et al. Wound healing recapitulates morphogenesis in Drosophila embryos. Nat. Cell Biol. \n                           4, 907\u201312 (2002).","journal-title":"Nat. Cell Biol."},{"key":"14571_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell \n                           100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"14571_CR13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3892\/ol.2013.1102","volume":"5","author":"C Yan","year":"2013","unstructured":"Yan, C. et al. RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cells. Oncol. Lett. \n                           5, 1031\u20131035 (2013).","journal-title":"Oncol. Lett."},{"key":"14571_CR14","doi-asserted-by":"publisher","first-page":"15894","DOI":"10.1073\/pnas.1208324109","volume":"109","author":"R Cao","year":"2012","unstructured":"Cao, R. et al. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc. Natl. Acad. Sci. \n                           109, 15894\u201315899 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"14571_CR15","doi-asserted-by":"crossref","unstructured":"Marchal, J. a. et al. Purification and Long-Term Expansion of Multipotent Endothelial-Like Cells with Potential Cardiovascular Regeneration. Stem Cells and Development \n                           21 (2012).","DOI":"10.1089\/scd.2011.0072"},{"key":"14571_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2016.04.036","volume":"377","author":"D Li","year":"2016","unstructured":"Li, D. et al. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects. Cancer Lett. \n                           377, 164\u2013173 (2016).","journal-title":"Cancer Lett."},{"key":"14571_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00270-008-9449-7","volume":"32","author":"D Pavcnik","year":"2009","unstructured":"Pavcnik, D. et al. Angiographic evaluation of carotid artery grafting with prefabricated small-diameter, small-intestinal submucosa grafts in sheep. Cardiovasc. Intervent. Radiol. \n                           32, 106\u2013113 (2009).","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"14571_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2009.03.002","volume":"1796","author":"A Voulgari","year":"2009","unstructured":"Voulgari, A. & Pintzas, A. Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochimica et Biophysica Acta - Reviews on Cancer \n                           1796, 75\u201390 (2009).","journal-title":"Biochimica et Biophysica Acta - Reviews on Cancer"},{"key":"14571_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan, L., Pantel, K. & Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med. \n                           19, 1450\u20131464 (2013).","journal-title":"Nat. Med."},{"key":"14571_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","volume":"291","author":"D Vergara","year":"2010","unstructured":"Vergara, D. et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. \n                           291, 59\u201366 (2010).","journal-title":"Cancer Lett."},{"key":"14571_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/mmr.2015.4550","volume":"13","author":"Y Yuan","year":"2016","unstructured":"Yuan, Y. et al. YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells. Mol. Med. Rep. \n                           13, 237\u2013242 (2016).","journal-title":"Mol. Med. Rep."},{"key":"14571_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3977","volume":"5","author":"A Parikh","year":"2014","unstructured":"Parikh, A. et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat. Commun. \n                           5, 2977 (2014).","journal-title":"Nat. Commun."},{"key":"14571_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1369\/0022155414538821","volume":"62","author":"SAI Adham","year":"2014","unstructured":"Adham, S. A. I. et al. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer. J. Histochem. Cytochem. \n                           62, 619\u201331 (2014).","journal-title":"J. Histochem. Cytochem."},{"key":"14571_CR24","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam, T. et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. \n                           69, 5820\u20135828 (2009).","journal-title":"Cancer Res."},{"key":"14571_CR25","first-page":"946","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada, S. et al. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surg. (United States) \n                           154, 946\u2013954 (2013).","journal-title":"Surg. (United States)"},{"key":"14571_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MPA.0b013e3181878b7f","volume":"38","author":"JMM Cates","year":"2009","unstructured":"Cates, J. M. M. et al. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas \n                           38, e1\u2013e6 (2009).","journal-title":"Pancreas"},{"key":"14571_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nrc1276","volume":"4","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro, U. & Christofori, G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer \n                           4, 118\u2013132 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"14571_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/carcin\/bgs225","volume":"33","author":"S Rachagani","year":"2012","unstructured":"Rachagani, S. et al. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis \n                           33, 1953\u20131964 (2012).","journal-title":"Carcinogenesis"},{"key":"14571_CR29","doi-asserted-by":"publisher","first-page":"e0154323","DOI":"10.1371\/journal.pone.0154323","volume":"11","author":"M Alaee","year":"2016","unstructured":"Alaee, M., Danesh, G. & Pasdar, M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS One \n                           11, e0154323 (2016).","journal-title":"PLoS One"},{"key":"14571_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1535-6108(02)00150-2","volume":"2","author":"K Suyama","year":"2002","unstructured":"Suyama, K., Shapiro, I., Guttman, M. & Hazan, R. B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell \n                           2, 301\u2013314 (2002).","journal-title":"Cancer Cell"},{"key":"14571_CR31","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","volume":"10","author":"S Nakajima","year":"2004","unstructured":"Nakajima, S. et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin. Cancer Res. \n                           10, 4125\u20134133 (2004).","journal-title":"Clin. Cancer Res."},{"key":"14571_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.canlet.2014.08.019","volume":"354","author":"KC Chiang","year":"2014","unstructured":"Chiang, K. C. et al. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells. Cancer Lett. \n                           354, 235\u2013244 (2014).","journal-title":"Cancer Lett."},{"key":"14571_CR33","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.2174\/09298673113209990251","volume":"20","author":"W Li","year":"2013","unstructured":"Li, W. et al. Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K\/Akt\/NF-\u03baB Pathway. Curr Med Chem \n                           20, 4185\u20134194 (2013).","journal-title":"Curr Med Chem"},{"key":"14571_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/jcmm.12300","volume":"18","author":"TS Huang","year":"2014","unstructured":"Huang, T. S. et al. Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells. J. Cell. Mol. Med. \n                           18, 1358\u20131371 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"14571_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","volume":"148","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell \n                           148, 1015\u20131028 (2012).","journal-title":"Cell"},{"key":"14571_CR36","doi-asserted-by":"crossref","unstructured":"Li, A. et al. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology \n                           146 (2014).","DOI":"10.1053\/j.gastro.2014.01.046"},{"key":"14571_CR37","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/md10051138","volume":"10","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog. Mar. Drugs \n                           10, 1138\u20131155 (2012).","journal-title":"Mar. Drugs"},{"key":"14571_CR38","doi-asserted-by":"crossref","first-page":"76656","DOI":"10.18632\/oncotarget.12307","volume":"7","author":"M Yang","year":"2016","unstructured":"Yang, M. et al. The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer. Oncotarget \n                           7, 76656\u201376666 (2016).","journal-title":"Oncotarget"},{"key":"14571_CR39","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-0829-3","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang, H., Li, M., Rinehart, J. J. & Zhang, R. Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts: In Vivo Activity, Pharmacokinetics, and Clinical Implications for Cancer Chemotherapy. Clin. Cancer Res. \n                           10, 1633\u20131644 (2004).","journal-title":"Clin. Cancer Res."},{"key":"14571_CR40","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology. PLoS One \n                           7 (2012).","DOI":"10.1371\/journal.pone.0044883"},{"key":"14571_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","volume":"170","author":"JE Talmadge","year":"2007","unstructured":"Talmadge, J. E., Singh, R. K., Fidler, I. J. & Raz, A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am. J. Pathol. \n                           170, 793\u2013804 (2007).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"14571_CR42","first-page":"98","volume":"47","author":"LI Partecke","year":"2011","unstructured":"Partecke, L. I. et al. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57\/BL6 mouse using the Panc02 and 6606PDA cell lines. Eur. Surg. \n                           47(2), 98\u2013107 (2011).","journal-title":"Surg."},{"key":"14571_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000055827","volume":"1","author":"XZ Ding","year":"2001","unstructured":"Ding, X. Z., Tong, W. G. & Adrian, T. E. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology \n                           1, 291\u2013299 (2001).","journal-title":"Pancreatology"},{"key":"14571_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.1154022","volume":"189","author":"C Liebow","year":"1975","unstructured":"Liebow, C. & Rothman, S. S. Enteropancreatic circulation of digestive enzymes. Science (80-.). \n                           189, 472\u2013474 (1975).","journal-title":"Science (80-.)."},{"key":"14571_CR45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0006-2952(87)90411-4","volume":"36","author":"E Ziv","year":"1987","unstructured":"Ziv, E., Lior, O. & Kidron, M. Absorption of protein via the intestinal wall. A quantitative model. Biochem. Pharmacol. \n                           36, 1035\u20131039 (1987).","journal-title":"Biochem. Pharmacol."},{"key":"14571_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00006676-200401000-00013","volume":"28","author":"K Gewert","year":"2004","unstructured":"Gewert, K., Holowachuk, S., Rippe, C., Gregory, P. & Pierzynowski, S. The enzyme levels in blood are not affected by oral administration of a pancreatic enzyme preparation (Creon 10,000) in pancreas-insufficient pigs. Pancreas \n                           28, 80\u201388 (2004).","journal-title":"Pancreas"},{"key":"14571_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00022.2001","volume":"82","author":"S Rothman","year":"2002","unstructured":"Rothman, S., Liebow, C. & Isenman, L. Conservation of digestive enzymes. Physiol. Rev. \n                           82, 1\u201318 (2002).","journal-title":"Physiol. Rev."},{"issue":"8","key":"14571_CR48","first-page":"2178","volume":"60","author":"JM Wood","year":"2000","unstructured":"Wood, J. M. et al. PTK787\/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-Induced Responses and Tumor Growth After Oral Administration. Cancer Research. \n                           60(8), 2178\u20132189 (2000).","journal-title":"Cancer Research."},{"key":"14571_CR49","doi-asserted-by":"crossref","unstructured":"Wallis, N. G. Anti-angiogenic activity of fragment-derived inhibitors of METAP2. Annals of Oncology. 23(Supplement 1), i26\u2013i44 (2012).","DOI":"10.1093\/annonc\/mds018"},{"key":"14571_CR50","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.12659\/MSM.898545","volume":"22","author":"L Weixin","year":"2016","unstructured":"Weixin, L. et al. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K\/Akt Signaling Pathway. Med. Sci. Monit. \n                           22, 4911\u20134917 (2016).","journal-title":"Med. Sci. Monit."},{"key":"14571_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1634\/stemcells.21-3-337","volume":"21","author":"B Annabi","year":"2003","unstructured":"Annabi, B. et al. Hypoxia Promotes Murine Bone-Marrow-Derived Stromal Cell Migration and Tube Formation. Stem Cells \n                           21, 337\u2013347 (2003).","journal-title":"Stem Cells"},{"key":"14571_CR52","first-page":"2215","volume":"62","author":"Y Ichigotani","year":"2002","unstructured":"Ichigotani, Y., Yokozaki, S., Fukuda, Y., Hamaguchi, M. & Matsuda, S. Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. Cancer Res. \n                           62, 2215\u20132219 (2002).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14571-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:30:03Z","timestamp":1671798603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14571-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14571"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14571-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"assertion":[{"value":"16 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Julian Kenyon is the Founder and Scientific Director of Propanc Pty Ltd and owns stock in the company. Propanc Pty Ltd has funded the University of Jaen and vivoPharm LLC to carry out this research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13998"}}